A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Modified RNA Vaccines Against Influenza in Healthy Adults

Clinical Trial Grant

Duke Scholars

Principal Investigator Emmanuel Benjamin Walter Jr. Pediatrics, General Pediatrics and Adolescent Health

Awarded By

Pfizer, Inc.

Start Date

May 6, 2024

End Date

May 5, 2025

Awarded By

Pfizer, Inc.

Start Date

May 6, 2024

End Date

May 5, 2025